Market TodayThemes and Stocks SummaryThematic Stock SearchCrypto SummaryFAQAbout
Robotic Surgery Stocks$86.66
-0.75%4:00PM 05/26/2023
The list of companies include MBOT-Microbot Medical Inc, STXS-Stereotaxis Inc, APM-Aptorum Group Ltd, ISRG-Intuitive Surgical Inc, MDT-Medtronic Plc, TMDI-Titan Medical Inc
Latest intraday update before market close @ 19:45:26 PM 05/26/2023
Summary :
Average return is down -0.4%
Median return is down -1.9%
2 out of 5 stocks are up (limited to those with intraday pricing feeds).

Aggregated price index

Aggregated price index with volume information


  • The momentum of the sector is very strong.
  • Robotic Surgery stocks down 0.8% on average while median return down 0.5% in a day
  • Robotic Surgery stocks up 9.1% on average while median return up -2.1% in a week
  • Robotic Surgery stocks up 27.2% on average while median return up 12.0% in a month
  • When average return is significantly different from median return, this implies an asymmetry - composite return is driven by some outliners.

Aggregated price index (close) is based on equal weighted constituencies returns. Average short volume and average total volumes are averaged across all volume data among constituencies.

Related Stocks

Click on + to show price series and click on ticker for stock detail page

1 Day Return
1 Week Return
1 Month Return
PE Ratio
P/B (mrq)
P/S (ttm)
Earning Growth
Short %
Held By Institutions %
Price Pattern
Resist Support
Days Since Channel Change
Channel Slope (daily rate %)
84.085.9610.2522.8736%107.5B1%88%61/\-/At resistance1340.2%
2.4717.1M5%22%65\Above resistance102-0.6%

* P/E and MarketCap are refreshed daily using IEX Cloud service. P/B, P/S, PEG, growth, short%, HelbyInstitute are refreshed weekly using Yahoo feeds. For latest stock stats please visit Yahoo Finance.

* Price Patter: / is upward trend, \ is downward trend, - is sideway. Click on the ticker to go to stock page to see Bayesian Trend model plot of the time series.

* Channel and change points are derived from Bayesian Trend model, where the channel slope is the growth rate while change points are those the model partition the time series.

Related ETFs (click on ticker for stock detail page)

leak data

  • 1M winners are : Winners for past month are $MBOT 38.4%, $STXS 32.1%
  • 1M losers are : Losers for past month are $MDT -10.9%
  • 1W winners are : Winners for past week are $MBOT 85.7%
  • 1W losers are : Losers for past week are $MDT -8.8%, $APM -14.1%
Pick two stocks to compare:

Correlation Analysis

Index correlation analysis

Correlation for the past month is -2.7%, for the past 3 months is 2.0%

In the past month for a 5 days rolling window, the highest corrrelation is 60.8%, the lowest correlation is -23.4%, the latest correlation is -23.4%

When a correlation deviated from the normal level and goes lower or even negative, it indicates some of stocks have deviated from the normal direction of the group. The deviation could reverse if long term level of correlation was at a higher level. It creates trading opportunities and deserves study whether the deviation is idiosyncratic or systematic.

Among pairwise correlation, the highest correlation is 34.4% between ISRG and MDT

The lowest correlation is -68.6% between ISRG and MBOT

Stock news

    Medtronic (MDT) to Expand Diabetes Care With New Buyout

    Medtronic's (MDT) latest acquisition will increase its capacity to assist more individuals with diabetes worldwide within a single, seamless Medtronic support ecosystem.

    2 Incredible Growth Stocks That Could Make a Comeback in 2023

    While no one can say when these choppy waters might subside, it's worth pointing out that the S&P 500 has still delivered a total return of 200% over the past 10 years and 67% over the last five. Intuitive Surgical (NASDAQ: ISRG) operates in one of the most non-cyclical industries on Earth -- the healthcare space. The company specializes in a very lucrative sub-sector of this industry: the surgical robotics market, a space that Grand View Research estimates is on track to be worth $18 billion ...

    Intuitive Surgical's (NASDAQ:ISRG) Returns On Capital Not Reflecting Well On The Business

    If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

    3 No-Brainer Stocks to Buy in a Correction

    NextEra Energy (NYSE: NEE) is a company well worth knowing about and adding to your watch list. The company bills itself as the world's largest utility company, and it can claim that in large part due to its ownership of the Florida Power & Light Company, which is itself "America's largest electric utility that sells more power than any other utility ..." There's a lot to like, or love, about NextEra Energy.

    Medtronic Slumps On Light Earnings Outlook; Announces $738 Million Buyout

    Medtronic beat fiscal fourth-quarter expectations Thursday and announced a buyout, but MDT stock dipped in premarket action.

    Medtronic (MDT) Q4 2023 Earnings Call Transcript

    Joining me are Geoff Martha, Medtronic chairman and chief executive officer; and Karen Parkhill, Medtronic chief financial officer. Geoff and Karen will provide comments on the results of our fourth quarter and fiscal year 2023, which ended on April 28, 2023, and our outlook for fiscal year '24.

    Medtronic (MDT) Q4 Earnings Beat Estimates, Margins Down

    Strong growth in the Cardiovascular, Medical Surgical, and Neuroscience portfolios, and in Diabetes markets drove Medtronic (MDT) Q4 revenues.

    Why Medtronic Stock Is Sinking Today

    Shares of the medical device maker Medtronic (NYSE: MDT) were down by 5% on heavy volume as of 10:53 a.m. ET Thursday. Although Medtronic topped Wall Street's consensus forecasts for the three-month period, investors appear to be reacting negatively to the company's financial guidance. Management blamed a stubbornly strong dollar and persistently high inflation for this softer-than-expected financial guidance.

    Medtronic Guidance Falls Short of Expectations. The Company Doesn’t Want Any More Misses.

    The company laid out guidance for its next fiscal year that fell well short of analyst expectations.

    Medtronic Stock Falls After Q4 Earnings and M&A Deal: Here's Why

    Medtronic Plc's (NYSE: MDT) reported Q4 FY23 sales of $8.54 billion, up 5.6% Y/Y as reported and organic, ahead of expectations, beating the consensus of $8.25 billion. Q4 revenue growth acceleration was broad-based, driven by procedure volume recovery, supply improvements, and innovative product introductions. Medtronic's heart device unit sales increased 12% Y/Y (+6.5% organic) to $3.2 billion. Spine & neurosurgery product segment sales increased 4.8% Y/Y (+6%) to $2.4 billion. Diabetes revenu